Usefulness of the GenMark ePlex RPP assay

Usefulness of the GenMark ePlex RPP assay for the detection of respiratory viruses in comparison with the FTD21 multiplex RT-PCR

Cartridge-based multiplex panels overlaying quite a few pathogens provide a bonus of minimal hands-on-time and quick time to consequence to business RT-PCR assays. On this research, we evaluated the efficiency of the ePlex respiratory pathogen panel (RPP) in comparison with the Quick Monitor Diagnostics Respiratory pathogens 21 multiplex RT-PCR assay (FTD21) utilizing 400 medical respiratory samples. Discrepant outcomes had been additional analysed by a reference nucleic acid amplification testing (NAT) and a composite reference method was used for ultimate interpretation. Discordant outcomes had been noticed in 56 targets equivalent to 54 samples. Sensitivities and specificities had been 85.5% and 99.9% for the ePlex RPP and 95.8% and 99.7% for the FTD21 system, respectively. Altogether, the ePlex RPP is a worthwhile device for the speedy detection of quite a lot of completely different respiratory viruses apart from the coronavirus household (low sensitivity starting from 50-80%) and samples with a low pathogen load (Ct values >33).
russelldurrett
russelldurrett

Type I Diabetes Serum, Human Donor

MBS170481-1Sample 1Sample
EUR 310

Type I Diabetes Serum, Human Donor

MBS170481-5Samples 5Samples
EUR 960

Type I Diabetes Serum, Human Donor

MBS170481-5x5Samples 5x5Samples
EUR 4110

Plasma - Type I Diabetes - Patient Sample

MBS170490-1Sample 1Sample
EUR 310

Plasma - Type I Diabetes - Patient Sample

MBS170490-5Samples 5Samples
EUR 1005

Plasma - Type I Diabetes - Patient Sample

MBS170490-5x5Samples 5x5Samples
EUR 4310

Human Muscle Myoblasts, Diabetes Type I

ABC-TC3956 1 vial Ask for price
Description: Diabetic Type I and Type II HSMM-Human Skeletal Muscle Myoblasts are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Scientific Support.

Single Donor Human Type I Diabetes Urine

IRHUURESDIBTI250ML each
EUR 1063
Description: Single Donor Human Type I Diabetes Urine

Single Donor Human Type I Diabetes Urine

IRHUURESDIBTI50ML each
EUR 439
Description: Single Donor Human Type I Diabetes Urine

Single Donor Human Type I Diabetes Urine

MBS8421330-250mL 250mL
EUR 1285

Single Donor Human Type I Diabetes Urine

MBS8421330-50mL 50mL
EUR 595

Single Donor Human Type I Diabetes Urine

MBS8421330-5x250mL 5x250mL
EUR 5540

Whole Blood - Type I Diabetes - Patient Sample

MBS170486-1Sample 1Sample
EUR 310

Whole Blood - Type I Diabetes - Patient Sample

MBS170486-5x1Sample 5x1Sample
EUR 4310

Preadipocytes, visc 1M cells, Diabetes Type I

LOPT-5023 each
EUR 1155.54

Preadipocytes, subcu 1M cells, Diabetes Type I

LOPT-5021 each
EUR 782.64

Diabetes (Type 1) Exosome

P141-DB1 - Ask for price

Diabetes (Type 2) Exosome

P141-DB2 - Ask for price

Human Type 2 Diabetes PB

ABC-TC4312 1 pack Ask for price
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's inability to compensate by producing more RI.

Human Type 1 Diabetes Leukopak

ABC-TC4310 1 pack Ask for price
Description: RI dependent diabetes, or Type 1 Diabetes is caused by the pancreas producing little to no RI.

Human Type 2 Diabetes Leukopak

ABC-TC4311 1 pack Ask for price
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's s inability to compensate by producing more RI.

Human Type I Diabetes Peripheral Blood Mononuclear Cells

ABC-TC4263 1 vial Ask for price
Description: Peripheral blood mononuclear cells are isolated from Type I Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type I PBMCs is available upon request.

Diabetes (Type 1) Exosome RNA

P241-DB1 - Ask for price

Diabetes (Type 2) Exosome RNA

P241-DB2 - Ask for price

D-Adipose-Derived stem cells, human, Type I Diabetes

LOPT-5007 each
EUR 748.19

Human Type II Diabetes PB Plasma

ABC-TC4266 1 vial Ask for price
Description: Type II Diabetes peripheral blood plasma is obtained by centrifugation of the Type II Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type II PB plasma is available upon request.

Type II Diabetes Serum, Human Donor

MBS170482-1Sample 1Sample
EUR 310

Type II Diabetes Serum, Human Donor

MBS170482-5Samples 5Samples
EUR 960

Type II Diabetes Serum, Human Donor

MBS170482-5x5Samples 5x5Samples
EUR 4110

Plasma - Type II Diabetes - Human Patient

MBS170491-1Sample 1Sample
EUR 310

Plasma - Type II Diabetes - Human Patient

MBS170491-5Samples 5Samples
EUR 1005

Plasma - Type II Diabetes - Human Patient

MBS170491-5x5Samples 5x5Samples
EUR 4310

Human iPS Cell Line (Type 2 Diabetes)

CSC-00849L One Frozen vial Ask for price

D-HAEC – Diseased Human Aortic Endothelial – Diabetes Type I

LOCC-2919 each
EUR 1920.94

Single Donor Human Type II Diabetes Urine

IRHUURESDIBTII250ML each
EUR 1063
Description: Single Donor Human Type II Diabetes Urine

Single Donor Human Type II Diabetes Urine

IRHUURESDIBTII50ML each
EUR 439
Description: Single Donor Human Type II Diabetes Urine

Single Donor Human Type II Diabetes Urine

MBS8421331-250mL 250mL
EUR 1285

Single Donor Human Type II Diabetes Urine

MBS8421331-50mL 50mL
EUR 595

Single Donor Human Type II Diabetes Urine

MBS8421331-5x250mL 5x250mL
EUR 5540

Human Muscle Myoblasts, Diabetes Type II

ABC-TC3957 1 vial Ask for price
Description: Diabetic Type I and Type II HSMM-Human Skeletal Muscle Myoblasts are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Scientific Support.

Whole Blood - Type II Diabetes - Patient Sample

MBS170487-1Sample 1Sample
EUR 310

Whole Blood - Type II Diabetes - Patient Sample

MBS170487-5x1Sample 5x1Sample
EUR 4310

D-AoSMC (Diseased Human Aortic Smooth Muscle), Diabetes Type I

LOCC-2914 each
EUR 1888.07

HighQC™ Human IPS Cell (Type 2 Diabetes)

ABC-SC0005T 1 vial Ask for price
Description: Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells . The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells.

Preadipocytes, visc 1M cells, Diabetes Type II

LOPT-5024 each
EUR 1155.54

Preadipocytes, subcu 1M cells, Diabetes Type II

LOPT-5022 each
EUR 782.64

D-CASMC – Diseased Human Coronary Artery Smooth Muscle – Diabetes Type I

LOCC-2917 each
EUR 1880.03

D-HMVEC – Diseased Cardiac Microvascular Endothelial Cells – Diabetes Type I

LOCC-2927 each
EUR 1299.42

D-HCAEC – Diseased Human Coronary Artery Endothelial Cells – Diabetes Type I

LOCC-2921 each
EUR 1884.64

Human Type II Diabetes Peripheral Blood Mononuclear Cells

ABC-TC4265 1 vial Ask for price
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays. A peripheral blood mononuclear cell is defined as any blood cell with a round nucleus. These blood cells are a critical component in the immune system to fight infection and adapt to intruders. The lymphocyte population consists of CD4+ and CD8+ T cells, B cells and Natural Killer cells, CD14+ Monocytes, and Basophils/Neutrophils/Eosinophils/Dendritic cells. These cells are often extracted from whole blood or from leukopacks using ficoll, a hydrophilic polysaccharide that separates layers of blood, with monocytes and lymphocytes forming a buffy coat under a layer of plasma.Samples from each donor are tested via PCR to confirm non-reactivity. Peripheral blood mononuclear cells are isolated from Type II Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type II PBMCs is available upon request.

D-HPAEC – Diseased Human Pulmonary Artery Endothelial Cells – Diabetes Type I

LOCC-2923 each
EUR 1920.94

D-Adipose-Derived stem cells, human, Type II Diabetes

LOPT-5008 each
EUR 748.19

D-PASMC (Diseased Human Pulmonary Artery Smooth Muscle Cells), Diabetes Type I

LOCC-2915 each Ask for price

D-HMVEC – Diseased Human Dermal Microvascular Endothelial Cells – Diabetes Type I

LOCC-2929 each
EUR 1169.49

D-HAEC – Diseased Human Aortic Endothelial – Diabetes Type II

LOCC-2920 each
EUR 1920.94

HighQC™ Human IPS Cell (Episomal/ Diabetes Type II/ Adipose)

ABC-SC0011T 1 vial Ask for price
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions.

D-AoSMC (Diseased Human Aortic Smooth Muscle), Diabetes Type II

LOCC-2916 each Ask for price

HighQC™ Human IPS Cell (IPSC From PBMC/ Diabetes Type II/ Episomal)

ABC-SC0009T 1 vial Ask for price
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions.

D-HCAEC – Diseased Human Coronary Artery Endothelial – Diabetes Type II

LOCC-2922 each
EUR 1884.64

D-CASMC – Diseased Human Coronary Artery Smooth Muscle – Diabetes Type II

LOCC-2918 each
EUR 1880.03

HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal)

ABC-SC0010T 1 vial Ask for price
Description: Gentaur is is proud to offer human iPS cell lines derived from the human dermal fibroblasts from patients with Type 2 Diabetes (T2D). The pertinent donor information is available upon request. These iPS cells are established from a single clone and expanded in feeder-free conditions. Normal human iPS cell lines are also available as separate products . We also provide custom iPSC generation and iPSC differentiation services to meet your needs.

D-HMVEC – Diseased Cardiac Microvascular Endothelial Cells – Diabetes Type II

LOCC-2928 each Ask for price

D-HEK-Ad – Diseased Human Adult Epidermal Keratinocytes – Diabetes Type II

LOCC-2926 each
EUR 841.52

D-HPAEC – Diseased Human Pulmonary Artery Endothelial Cells – Diabetes Type II

LOCC-2924 each Ask for price

HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cell/ Type II Diabetes Patient

ABC-SC0027T 1 vial Ask for price
Description: Human MSCs (Bone Marrow Derived) from a single adult donor clinically diagnosed with Type II Diabetes. The MSCs are compatible with our MSC Expansion Medium for Bone Marrow Derived MSCs.All of the cells provided are tested and are negative for HIV-1, HIV-2, Hepatitis B and Hepatitis C as detected by PCR. The cells are confirmed to be negative for mycoplasma and other detectable microbial contamination.

D-PASMC (Diseased Human Pulmonary Artery Smooth Muscle Cells), Diabetes Type II

LOCC-2913 each
EUR 1935.75

D-HMVEC – Diseased Human Dermal Microvascular Endothelial Cells – Diabetes Type II

LOCC-2930 each Ask for price

Linearity FD Special Diabetes

K889M-5 5 x 2 mL
EUR 374

D-RPTEC – Diseased Human Renal Proximal Tubule Epithelial Cells – Diabetes Type II

LOCC-2925 each
EUR 2091.71

Human Diabetes Lung Tissue Lysate

IHULGDIBTL100UG each
EUR 1413
Description: Human Diabetes Lung Tissue Lysate

Single Donor Human Diabetes Serum

ISERSDIB each
EUR 209
Description: Single Donor Human Diabetes Serum

Single Donor Human Diabetes Serum

MBS8421607-INQUIRE INQUIRE Ask for price

Human Diabetes Lung Tissue Lysate

MBS8414460-01mg 0.1mg
EUR 1810

Human Diabetes Lung Tissue Lysate

MBS8414460-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Ileum Tissue Lysate

IHUILMDIBTL100UG each
EUR 1413
Description: Human Diabetes Ileum Tissue Lysate

Human Diabetes Colon Tissue Lysate

IHUCLNDIBTL100UG each
EUR 1413
Description: Human Diabetes Colon Tissue Lysate

Single Donor Human Diabetes Plasma

IPLASDIB each
EUR 209
Description: Single Donor Human Diabetes Plasma

Human Diabetes Colon Tissue Lysate

MBS139594-01mg 0.1mg
EUR 1810

Human Diabetes Colon Tissue Lysate

MBS139594-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Ileum Tissue Lysate

MBS8413586-01mg 0.1mg
EUR 1810

Human Diabetes Ileum Tissue Lysate

MBS8413586-5x01mg 5x0.1mg
EUR 7965

Single Donor Human Diabetes Plasma

MBS8421060-INQUIRE INQUIRE Ask for price

Human Diabetes Jejunum Tissue Lysate

IHUJEJDIBTL100UG each
EUR 1413
Description: Human Diabetes Jejunum Tissue Lysate

Human Diabetes Stomach Tissue Lysate

IHUSTDIBTL100UG each
EUR 1413
Description: Human Diabetes Stomach Tissue Lysate

Human Diabetes Jejunum Tissue Lysate

MBS8413808-01mg 0.1mg
EUR 1810

Human Diabetes Jejunum Tissue Lysate

MBS8413808-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Stomach Tissue Lysate

MBS8420033-01mg 0.1mg
EUR 1810

Human Diabetes Stomach Tissue Lysate

MBS8420033-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Duodenum Tissue Lysate

IHUDUODIBTL100UG each
EUR 1413
Description: Human Diabetes Duodenum Tissue Lysate

Human Diabetes Pancreas Tissue Lysate

IHUPCSDIBTL100UG each
EUR 1413
Description: Human Diabetes Pancreas Tissue Lysate

Human Diabetes Pancreas Tissue Lysate

MBS8416917-01mg 0.1mg
EUR 1810

Human Diabetes Pancreas Tissue Lysate

MBS8416917-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Duodenum Tissue Lysate

MBS8410767-01mg 0.1mg
EUR 1810

Human Diabetes Duodenum Tissue Lysate

MBS8410767-5x01mg 5x0.1mg
EUR 7965

Human Diabetes Esophagus Tissue Lysate

IHUESOPDIBTL100UG each
EUR 1413
Description: Human Diabetes Esophagus Tissue Lysate

Human Diabetes Esophagus Tissue Lysate

MBS8411234-01mg 0.1mg
EUR 1810

Human Diabetes Esophagus Tissue Lysate

MBS8411234-5x01mg 5x0.1mg
EUR 7965

Human Diabetes AdiposeVisceral Tissue Lysate

IHUADPTVDIBTL100UG each
EUR 2663
Description: Human Diabetes AdiposeVisceral Tissue Lysate

Human Diabetes AdiposeVisceral Tissue Lysate

MBS136954-01mg 0.1mg
EUR 3320

Human Diabetes AdiposeVisceral Tissue Lysate

MBS136954-5x01mg 5x0.1mg
EUR 14765

Human Diabetes Skeletal Muscle Tissue Lysate

IHUSKMDIBTL100UG each
EUR 1413
Description: Human Diabetes Skeletal Muscle Tissue Lysate

Human Diabetes Skeletal Muscle Tissue Lysate

MBS8419496-01mg 0.1mg
EUR 1810

Human Diabetes Skeletal Muscle Tissue Lysate

MBS8419496-5x01mg 5x0.1mg
EUR 7965

Human Diabetes AdiposeSubcutaneous Tissue Lysate

IHUADPTSDIBTL100UG each
EUR 2663
Description: Human Diabetes AdiposeSubcutaneous Tissue Lysate

Human Diabetes AdiposeSubcutaneous Tissue Lysate

MBS136950-01mg 0.1mg
EUR 3320

Human Diabetes AdiposeSubcutaneous Tissue Lysate

MBS136950-5x01mg 5x0.1mg
EUR 14765

Diabetes Drug Leads Bioactive Peptide Library

L-012 160 peptides
EUR 7938

Human Diabetes Pancreas Lysate Membrane Fraction

IHUPCSDIBTLM100UG each
EUR 1199
Description: Human Diabetes Pancreas Lysate Membrane Fraction

Human Diabetes Pancreas Lysate Membrane Fraction

MBS8416918-01mg 0.1mg
EUR 1550

Human Diabetes Pancreas Lysate Membrane Fraction

MBS8416918-5x01mg 5x0.1mg
EUR 6780

Linearity FLQ Special Diabetes for Roche Systems

K929M-5 5 x 2 mL
EUR 374

Tissue, Section, Human Disease, Diabetes, Eye (Frozen)

MBS640656-5Slides 5Slides
EUR 930

Tissue, Section, Human Disease, Diabetes, Eye (Frozen)

MBS640656-5x5Slides 5x5Slides
EUR 3955

Tissue, Total Protein, Human Disease, Diabetes, Lung

MBS657041-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Lung

MBS657041-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Skin

MBS657133-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Skin

MBS657133-5x1mg 5x1mg
EUR 3470

Linearity FLQ Special Diabetes for Abbott Systems

K956M-5 5 x 2 mL
EUR 374

Tissue, Section, Human Disease, Diabetes, Skin (Frozen)

MBS640139-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Skin (Frozen)

MBS640139-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Lung (Frozen)

MBS640535-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Lung (Frozen)

MBS640535-5x5Slides 5x5Slides
EUR 3170

Tissue, Total Protein, Human Disease, Diabetes, Brain

MBS657014-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Brain

MBS657014-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Liver

MBS657060-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Liver

MBS657060-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Colon

MBS657406-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Colon

MBS657406-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Heart

MBS657486-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Heart

MBS657486-5x1mg 5x1mg
EUR 3470

Tissue, Section, Human Disease, Diabetes, Liver (Frozen)

MBS640704-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Liver (Frozen)

MBS640704-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Brain (Frozen)

MBS640760-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Brain (Frozen)

MBS640760-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Colon (Frozen)

MBS640835-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Colon (Frozen)

MBS640835-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Heart (Frozen)

MBS640578-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Heart (Frozen)

MBS640578-5x5Slides 5x5Slides
EUR 3170

Tissue, Total Protein, Human Disease, Diabetes, Spleen

MBS657230-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Spleen

MBS657230-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Kidney

MBS657520-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Kidney

MBS657520-5x1mg 5x1mg
EUR 3470

Tissue, Section, Human Disease, Diabetes, Kidney (Frozen)

MBS639978-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Kidney (Frozen)

MBS639978-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Spleen (Frozen)

MBS640944-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Spleen (Frozen)

MBS640944-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Lung (Paraffin)

MBS640452-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Lung (Paraffin)

MBS640452-5x5Slides 5x5Slides
EUR 2145

Tissue, Total Protein, Human Disease, Diabetes, Adrenal

MBS657074-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Adrenal

MBS657074-5x1mg 5x1mg
EUR 3470

Tissue, Total Protein, Human Disease, Diabetes, Stomach

MBS657368-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Stomach

MBS657368-5x1mg 5x1mg
EUR 3470

Tissue, Section, Human Disease, Diabetes, Adrenal (Frozen)

MBS640239-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Adrenal (Frozen)

MBS640239-5x5Slides 5x5Slides
EUR 3170

Tissue, Section, Human Disease, Diabetes, Colon (Paraffin)

MBS640373-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Colon (Paraffin)

MBS640373-5x5Slides 5x5Slides
EUR 2145

Tissue, Section, Human Disease, Diabetes, Liver (Paraffin)

MBS640786-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Liver (Paraffin)

MBS640786-5x5Slides 5x5Slides
EUR 2145

Tissue, Section, Human Disease, Diabetes, Stomach (Frozen)

MBS640568-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Stomach (Frozen)

MBS640568-5x5Slides 5x5Slides
EUR 3170

Tissue, Total Protein, Human Disease, Diabetes, Pancreas

MBS657129-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Pancreas

MBS657129-5x1mg 5x1mg
EUR 3470

Tissue, Section, Human Disease, Diabetes, Pancreas (Frozen)

MBS640252-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Pancreas (Frozen)

MBS640252-5x5Slides 5x5Slides
EUR 3170

Tissue, Total Protein, Human Disease, Diabetes, Esophagus

MBS657305-1mg 1mg
EUR 820

Tissue, Total Protein, Human Disease, Diabetes, Esophagus

MBS657305-5x1mg 5x1mg
EUR 3470

Tissue, Section, Human Disease, Diabetes, Stomach (Paraffin)

MBS640658-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Stomach (Paraffin)

MBS640658-5x5Slides 5x5Slides
EUR 2145

Tissue, Section, Human Disease, Diabetes, Esophagus (Frozen)

MBS640725-5Slides 5Slides
EUR 755

Tissue, Section, Human Disease, Diabetes, Esophagus (Frozen)

MBS640725-5x5Slides 5x5Slides
EUR 3170

Human Diabetes Skeletal Muscle Lysate Membrane Fraction

IHUSKMDIBTLM100UG each
EUR 1199
Description: Human Diabetes Skeletal Muscle Lysate Membrane Fraction

Tissue, Membrane Protein, Human Disease, Diabetes, Pancreas

MBS639798-01mg 0.1mg
EUR 695

Tissue, Membrane Protein, Human Disease, Diabetes, Pancreas

MBS639798-5x01mg 5x0.1mg
EUR 2915

Tissue, Section, Human Disease, Diabetes, Pancreas (Paraffin)

MBS639953-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Pancreas (Paraffin)

MBS639953-5x5Slides 5x5Slides
EUR 2145

Human Diabetes Skeletal Muscle Lysate Membrane Fraction

MBS8419497-01mg 0.1mg
EUR 1550

Human Diabetes Skeletal Muscle Lysate Membrane Fraction

MBS8419497-5x01mg 5x0.1mg
EUR 6780

Tissue, Total Protein, Human Disease, Diabetes, Whole Eye

MBS657222-1mg 1mg
EUR 1430

Tissue, Total Protein, Human Disease, Diabetes, Whole Eye

MBS657222-5x1mg 5x1mg
EUR 6225

Tissue, Section, Human Disease, Diabetes, Esophagus (Paraffin)

MBS640383-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Esophagus (Paraffin)

MBS640383-5x5Slides 5x5Slides
EUR 2145

Tissue, Total Protein, Human Disease, Diabetes, Bone Marrow

MBS657533-1mg 1mg
EUR 1430

Tissue, Total Protein, Human Disease, Diabetes, Bone Marrow

MBS657533-5x1mg 5x1mg
EUR 6225

Tissue, Section, Human Disease, Diabetes, Bone Marrow (Frozen)

MBS640718-5Slides 5Slides
EUR 930

Tissue, Section, Human Disease, Diabetes, Bone Marrow (Frozen)

MBS640718-5x5Slides 5x5Slides
EUR 3955

Tissue, Section, Human Disease, Diabetes, Bone Marrow (Paraffin)

MBS640435-5Slides 5Slides
EUR 510

Tissue, Section, Human Disease, Diabetes, Bone Marrow (Paraffin)

MBS640435-5x5Slides 5x5Slides
EUR 2145

Tissue, Total Protein, Human Disease, Diabetes, Skeletal Muscle

MBS657193-1mg 1mg
EUR 820

Mixture of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Analysis

Background: Coronavirus illness 2019 (COVID-19), brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mostly recognized by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases just a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (roughly 80%). We evaluated the efficiency of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the mixture of RT-PCR and the IgG assay for COVID-19 analysis.
Strategies: On this retrospective research, 206 samples from 70 COVID-19 instances at two hospitals in Tokyo that had been constructive utilizing RT-PCR had been used to investigate the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Pink Cross Society (N=100) samples had been used to guage specificity.
Outcomes: Sensitivity elevated day by day after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case teams. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 instances with a number of samples and from one other case with a constructive consequence within the IgG assay for the primary accessible pattern.
Conclusions: The mix of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the constraints of every technique.

Simultaneous Molecular Detection of Frequent Bacterial Enteropathogens in Youngsters with Diarrhea by Multiplex-PCR Assay

Background: Diarrhea stays a serious risk to kids in low- and middle-income international locations, which is the second explanation for dying amongst kids on the planet. The intention of the current research was to develop and consider a multiplex-PCR assay for direct detection of widespread bacterial enteropathogens in fecal specimens.
Strategies: 100 and three stool specimens had been collected from kids beneath 5 years of age with gastroenteritis throughout a six-month interval in Ilam, Iran. The multiplex PCR assay concurrently detected Shigella spp., Campylobacter jejuni, Enteropathogenic Escherichia coli (EPEC), Enterotoxigenic Escherichia coli (ETEC), and Salmonella enterica in stool samples.
Outcomes: Our outcomes demonstrated that the prevalence of Shigella spp. Campylobacter jejuni, EPEC, ETEC, and Salmonella enterica had been 21.35%, 10.67%, 1.94%, 0.97% and 0%, respectively. As well as, Shigella spp. with Campylobacter jejuni and EPEC with Campylobacter jejuni coinfection had been noticed in pattern 11 (10.67%). The analytical sensitivity of the multiplex PCR assay was estimated to be 0.01 ng/µL of genomic DNA from tradition. The analytical specificity was decided to be 100% through the use of widespread and customary enteropathogenic bacterial strains.
Conclusions: The molecular technique developed within the research was speedy, delicate, and particular for detection of widespread bacterial enteropathogens.

Screening of ZIKA virus an infection amongst dengue-like sickness sufferers with damaging RT-PCR for dengue virus in Punjab – Pakistan

Goal: To detect ZIKV utilizing reverse transcription-polymerase chain response (RT-PCR) amongst medical samples examined damaging for Dengue virus (DENV) by RT-PCR in Punjab, 2016.
Strategies: A descriptive cross-sectional research was carried out for length of two months. Whole of 506 samples had been collected inside seven days from onset of sickness from throughout hospitals of Punjab, Pakistan of which 350 had been chosen merely randomly to check for presence of ZIKV through the use of “Trioplex Actual-Time RT-PCR Assay (Trioplex)”. Cohen’s kappa coefficient (κ) and 95% confidence interval (CI) had been used to evaluate the diploma of concordance between DENV constructive outcomes of non-structural protein 1 (NS1) and IgM solid-phase enzyme immunoassay (ELISA).
Outcomes: No samples had been constructive for any ZIKV, DENV or Chikungunya virus (CHIKV) by Trioplex. Among the many 350 samples, 26 samples had been constructive concordant and the diploma of concordance between NS1- and IgM-ELISA was 13% and κ coefficient was -0.71 (95% CI -0.79, -0.63).
Conclusion: At research time, no samples had been constructive for ZIKV. Strengthening laboratory capability to verify arboviruses for Punjab’s laboratories is warranted. Trioplex RT-PCR has 100% sensitivity so there are nominal probabilities of false damaging outcomes. Establishing syndromic surveillance for Zika and conducting a sero-surveillance survey for Zika in areas with excessive human and Aedes mosquito density are advisable in Punjab.

Repositive RT-PCR take a look at in discharged COVID-19 sufferers throughout medical isolation commentary

Targets: The epidemiological and medical traits of sufferers with coronavirus illness 2019 (COVID-19) have been researched. Nonetheless, the prevalence of repositivity by real-time PCR for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stays unclear.
Strategies: A retrospective research was carried out involving 599 discharged sufferers with COVID-19 in a single medical centre. The medical options of sufferers throughout their hospitalization and 14-day post-discharge quarantine had been collected.
Outcomes: A complete of 122 sufferers (20.4%) out of 599 sufferers retested constructive after discharge. Particularly, 94 (15.7%) retested constructive inside 24 h of discharge, and one other 28 sufferers (4.7%) had been repositive on day 7 after discharge, though none confirmed any medical symptomatic recurrence. Each repositives and non‑repositives have related patterns of IgG and IgM. Notably, the size of hospitalization of non-repositive sufferers was longer than that of 24-h repositive sufferers and 7-day repositive sufferers. As well as, the size of hospitalization of 24-h repositive sufferers was shorter than that of 7-day repositive sufferers, indicating that the size of hospitalization was additionally a determinant of viral shedding.
Conclusion: Our research supplies additional info for bettering the administration of recovered and discharged sufferers, and additional research must be carried out to elucidate the infectiveness of people with extended or RNA repositivity.

Leave a Reply

Your email address will not be published. Required fields are marked *